Curtiss-Wright to Benefit From Strength in Nuclear, Defense Segments, Morgan Stanley Says

MT Newswires Live11-11

Curtiss-Wright (CW) continues to benefit from strength in its commercial nuclear and defense businesses, Morgan Stanley said Monday in a report.

Momentum in the commercial nuclear segment is building, driven by rising demand for AP1000 reactors and higher projected shipset value per plant, while defense electronics margins rose close to a record in Q3, the report said.

Curtiss-Wright's strong execution and robust cash generation are expected to offset higher investment needs, while the near-term impact from the US government shutdown should be temporary, the report said.

Morgan Stanley raised its price target on Curtiss-Wright stock to $645 from $565 and reiterated its overweight rating.

Price: 590.73, Change: +12.14, Percent Change: +2.10

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment